CC-5

N/A

Report date: 2024/11/15 09:59:59
NME

Base Information

Drug NameCC-5
Drug Alias NameCC-5
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action5'-nucleotidase inhibitorsProgrammed death-ligand 1 blockers
TargetsProgrammed death-ligand 15'-nucleotidase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWenzhou Medical UniversitySouth China University Of TechnologySouthern Medical University, China +[4] 
China Registration ClassN/A

Develop Information

Active CompaniesSouth China University Of TechnologyHubei University of TechnologySouthern Medical University, China +[4] 
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A